NAD+ IV Infusion

NAD+ IV infusion represents an emerging therapeutic approach that aims to directly restore cellular levels of this critical coenzyme through intravenous delivery. Research indicates that NAD+ plays essential roles in mitochondrial energy production, DNA repair, and cellular stress response, with studies suggesting that declining NAD+ levels may contribute to age-related cellular dysfunction. The intravenous route theoretically bypasses the digestive system's breakdown of NAD+ compounds, potentially achieving higher bioavailability than oral supplementation.

Current research on NAD+ IV therapy remains limited, with most human studies focusing on safety profiles rather than efficacy outcomes. Small pilot studies have explored its effects on fatigue, cognitive function, and metabolic markers, though results remain preliminary and inconsistent. The therapy typically involves 1-3 hour infusion sessions, with practitioners often combining NAD+ with other compounds like B-vitamins or amino acids, though studies suggest the optimal protocols are not yet established.

While generally well-tolerated in healthy adults, research indicates that NAD+ IV infusions can cause side effects including nausea, cramping, and anxiety during administration. The high cost and time commitment, combined with limited regulatory oversight in many jurisdictions, means patients should carefully evaluate the risk-benefit profile. Long-term safety data remains sparse, and studies suggest that more research is needed to establish both optimal dosing protocols and clinical efficacy for specific health outcomes.